In Europe and in other countries such as Australia and New Zealand (sold as Difur and Leucostat), our product is a well recognized immuno-modulator (not immune suppressor), and through its Th1/Th2 modulating abilities, it is able to help about 80% of all psoriasis patients within 12 weeks of use, and when the period of use is extended to 6-12 months, the success rate is dramatically increased (thi